Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001969802 | SCV002224939 | uncertain significance | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2021-08-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002497824 | SCV002777805 | uncertain significance | Epilepsy, childhood absence, susceptibility to, 6; Hyperaldosteronism, familial, type IV | 2022-03-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002562816 | SCV003660845 | uncertain significance | Inborn genetic diseases | 2022-11-21 | criteria provided, single submitter | clinical testing | The c.5480A>G (p.H1827R) alteration is located in exon 33 (coding exon 32) of the CACNA1H gene. This alteration results from a A to G substitution at nucleotide position 5480, causing the histidine (H) at amino acid position 1827 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |